Pharmaceutical companies are likely to report a moderate or near-flat revenue growth in the third quarter, while the profit for many of them may slip owing ... generic adoption reaching saturation levels and regulatory overhang along with base effect catching up, the Indian pharma sector is likely to curtail ...
Read more: Intensified competition to weigh on pharma companies' Q3 performance